Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?

Neuroscientist

Volumn 19, Issue 4, 2013, Pages 345-353

  Carlino, Davide ^a   De Vanna, Maurizio ^a   Tongiorgi, Enrico ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Alzheimer's disease; cognitive impairment; convertase; neurotrophin; schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MEMBRANE BOUND TRANSCRIPTION FACTOR SITE 1 PROTEASE; PROTEINASE; SERINE PROTEINASE; SUBTILISIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN DISEASE; COGNITION; COGNITIVE DEFECT; DEPRESSION; HIPPOCAMPUS; LEARNING; MEMORY; MILD COGNITIVE IMPAIRMENT; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE;

ALZHEIMER'S DISEASE; COGNITIVE IMPAIRMENT; CONVERTASE; NEUROTROPHIN; SCHIZOPHRENIA;

ANIMALS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; HUMANS; LEARNING; MEMORY; MICE; MICE, KNOCKOUT;

EID: 84878781963     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858412469444     Document Type: Article

References (61)

1. Akaneya Y, Tsumoto T, Hatanaka H. Brain-derived neurotrophic factor blocks long-term depression in rat visual cortex. J Neurophysiol. 1996 ; 76 (6). 4198-201
2. Akhondzadeh S, Stone T. Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor. Prog Neuropsychopharmacol Biol Psychiatry. 1999 ; 23 (7). 1215-26
3. Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, Colantoni L. Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res. 2010 ; 7 (1). 15-20
4. Arancio O, Chao MV. Neurotrophins, synaptic plasticity and dementia. Curr Opin Neurobiol. 2007 ; 17: 325-30
5. Archer T, Kostrzewa RM, Beninger RJ, Palomo T. Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions. Neurotox Res. 2011 ; 19 (2). 211-34
6. Barnes P, Thomas KL. Proteolysis of proBDNF is a key regulator in the formation of memory. PloS ONE. 2008 ; 3 (9). e3248
7. Buckley PF, Mahadik S, Pillai A, Terry A. Neurotrophins and schizophrenia. Schizophr Res. 2007 ; 94 (1-3). 1-11
8. Carlino D, Leone E, Di Cola F, Baj G, Marin R, Dinelli G. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. J Psychiatr Res. 2011 ; 45 (2). 273-9
9. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol. 2008 ; 153: S310-24
10. Costa-Mattioli M, Gobert D, Stern E, Gamache K, Colina R, Cuello C. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell. 2007 ; 129 (1). 195-206
11. Ding Q, Ying Z, Gómez-Pinilla F. Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing. Neuroscience. 2011 ; 29 (192). 773-80
12. Diniz BS, Pinto JA, Gonzaga ML, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2009 ; 259 (4). 248-56
13. Dogliotti G, Galliera E, Licastro F, Corsi MM. Age-related changes in plasma levels of BDNF in Down syndrome patients. Immun Ageing. 2010 ; 25 (7). 2
14. Dunham JS, Deakin JFW, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res. 2009 ; 43: 1175-84
15. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003 ; 23 (19). 7311-6
16. Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry. 2010 ; 11 (6). 774-80
17. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry. 2011 ; 16 (9). 960-72
18. Griesbach GS, Hovda DA, Gomez-Pinilla F. Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 2009 ; 1288: 105-15
19. Gorski JA, Balogh SA, Wehner JM, Jones KR. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience. 2003 ; 121 (2). 341-54
20. Greenberg ME, Xu B, Lu B, Hempstead BL. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci. 2009 ; 29 (41). 12764-7
21. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 2001 ; 411 (6833). 86-9
22. Hill RA, Murray SS, Halley PG, Binder MD, Martin SJ, van den Buuse M. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hippocampus. 2011 ; 21 (4). 434-45
23. Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP. Extinction memory is impaired in schizophrenia. Biol Psychiatry. 2009 ; 65 (6). 455-63
24. Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 1995 ; 267 (5204). 1658-62
25. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of ante mortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res. 2005 ; 136 (1-2). 29-37
26. Kinoshita S, Yasuda H, Taniguchi N, Katoh-Semba R, Hatanaka H, Tsumoto T. Brain-derived neurotrophic factor prevents low-frequency inputs from inducing long-term depression in the developing visual cortex. J Neurosci. 1999 ; 19 (6). 2122-30
27. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 1995 ; 92 (19). 8856-60
28. Korte M, Griesbeck O, Gravel C, Carroll P, Staiger V, Thoenen H. Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci U S A. 1996 ; 93 (22). 12547-52
29. Koshimizu H, Kiyosue K, Hara T, Hazama S, Suzuki S, Uegaki K. Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain. 2009 ; 2: 27
30. LaLumiere RT, Nawar EM, McGaugh JL. Modulation of memory consolidation by the basolateral amygdala or nucleus accumbens shell requires concurrent dopamine receptor activation in both brain regions. Learn Mem. 2005 ; 12: 296-301
31. Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res. 2007 ; 41 (5). 387-94
32. Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm. 2006 ; 113 (9). 1217-24
33. Lee JG, Shin BS, You YS, Kim JE, Yoon SW, Jeon DW. Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatry Invest. 2009 ; 6 (4). 299-305
34. Lee JL, Everitt BJ, Thomas KL. Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science. 2004 ; 304 (5672). 839-43
35. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science. 2001 ; 294 (5548). 1945-8
36. Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J Alzheimers Dis. 2009 ; 16 (3). 649-56
37. Linnarsson S, Björklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci. 1997 ; 9 (12). 2581-7
38. Lohof AM, Ip NY, Poo MM. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature. 1993 ; 363 (6427). 350-3
39. Ma YL, Wang HL, Wu HC, Wei CL, Lee EH. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience. 1998 ; 82 (4). 957-67
40. Michalski B, Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Mol Brain Res. 2003 ; 111 (1-2). 148-54
41. Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int. 2000 ; 36 (3). 197-202
42. Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem. 2001 ; 276 (16). 12660-6
43. Nagappan G, Zaitsev E, Senatorov VV, Yang J, Hempstead BL, Lu B. Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci U S A. 2009 ; 106 (4). 1267-72
44. Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011 ; 37: 33-40
45. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 2004 ; 306 (5695). 487-91
46. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 1996 ; 16 (6). 1137-45
47. Patterson SL, Grover LM, Schwartzkroin PA, Bothwell M. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron. 1992 ; 9 (6). 1081-8
48. Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem. 2005 ; 93 (6). 1412-21
49. Raymond CR. LTP forms 1, 2 and 3: different mechanisms for the "long" in long-term potentiation. Trends Neurosci. 2007 ; 30 (4). 167-75
50. Rodrigues SM, Schafe GE, LeDoux JE. Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron. 2004 ; 44 (1). 75-91
51. Scamuffa N, Calvo F, Chrétien M, Seidah NG, Khatib AM. Proprotein convertases: lessons from knockouts. FASEB J. 2006 ; 20 (12). 1954-63
52. Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000 ; 23 (12). 639-45
53. Seidah NG, Mowla SJ, Hamelin J, Mamarbachi AM, Benjannet S, Touré BB. Mammalian subtilisin/kexin isozyme SKI-1: a widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc Natl Acad Sci U S A. 1999 ; 96 (4). 1321-6
54. Sermasi E, Margotti E, Cattaneo A, Domenici L. Trk B signalling controls LTP but not LTD expression in the developing rat visual cortex. Eur J Neurosci. 2000 ; 12 (4). 1411-9
55. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci. 2005 ; 25 (22). 5455-63
56. Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?. Biol Psychiatry. 2009 ; 66 (6). 549-53
57. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003 ; 8 (6). 592-610
58. Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS. Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience. 2010 ; 169 (3). 1071-84
59. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci. 2005 ; 8 (8). 1069-77
60. Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. Serum BDNF, TNF-α and IL-1b levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2006 ; 256 (7). 402-6
61. Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One. 2012 ; 7 (8). e42676